Part of the Altiras360 product family
Demo Get Started

Legal

Medication & Compounding Disclosure.

Licensed prescribing and dispensing, approved drugs and compounded preparations.

Last updated November 18, 2026.

This disclosure applies to prescription medication programs accessed through Altiras Telemeds Solutions or a business using its platform, where those programs are actually offered in the patient's state.

1. Licensed prescribing and dispensing

Altiras Telemeds Solutions is a non-clinical website brand. MedSpace US is a technology/EMR integration partner. Neither role allows medical practice or pharmacy activity. Medication is prescribed, if at all, by an appropriately licensed independent healthcare professional after an individual evaluation, and dispensed by a properly licensed pharmacy. The prescriber and pharmacy may each decline, change, delay or cancel a prescription for lawful clinical or safety reasons.

2. No promised prescription or shipment

Viewing a medication page, submitting an intake, paying for a consultation or requesting a product is not a prescription and does not ensure one. The provider may recommend another option, require an exam or labs, or decide medication is not appropriate. Pharmacy fulfillment depends on a valid prescription, eligibility, inventory, state rules and carriers.

3. Approved drugs and compounded preparations

Products approved by the FDA have been reviewed by the agency for safety and effectiveness for their approved uses. Compounded preparations have not gone through FDA premarket approval and are not automatically equivalent to, interchangeable with or generic versions of approved products. A compounded preparation is not approved because its ingredients are known or the compounder is licensed or registered. Compounding a copy of an approved drug is lawful only when every applicable condition is met.

4. Compounding eligibility and individual need

If a compounded medication is clinically indicated and lawful, the independent clinician documents the patient-specific reasons and the pharmacy performs any required legal assessment. Altiras Telemeds Solutions makes no general claim that semaglutide, tirzepatide or any other named medication may lawfully be compounded, prescribed, marketed or shipped in every state.

5. Risks and counseling

Risks vary with the drug, use, route, ingredients, strength and patient. For weight-management medicines, risks may include gastrointestinal effects, dehydration, pancreatitis, gallbladder problems, allergic reactions, changes in blood sugar and other warnings in the prescribing information. Certain approved GLP-1/GIP medicines carry boxed warnings about thyroid C-cell tumors. Review contraindications, pregnancy considerations, interactions, storage, administration, missed doses and serious symptoms with the prescriber and pharmacist. Compounded forms can carry added strength, labeling, measuring, contamination and dosing-error risks.

6. Pharmacy identity and patient rights

Before dispensing, the patient receives the pharmacy's identity, the prescription and dispensing details the law requires, pharmacist contact details and instructions. Pharmacy licensure and lawful shipment to the patient's state are verified. Patients may ask for pharmacist counseling and can report suspected quality problems or side effects.

7. Pricing, returns and substitutions

A medication price may differ from the consultation, lab, program or shipping price. Substitutions, shortages, returns, cancellations, temperature-sensitive handling, delays and refund exceptions follow the law and the pharmacy and order terms shown before payment.

8. Advertising and product claims

Businesses on the platform may not state or imply that a compounded medicine is approved or is an identical, bioequivalent or generic version of a branded medicine, use manufacturer logos or trademarks to suggest endorsement, or make unsupported therapeutic claims. See Business Partner Terms.

9. Program details

Each medication program shows its ingredients, whether the drug is approved or compounded, its use, material safety risks, contraindications, eligibility, price components, the supervising clinician and the pharmacy before a patient commits. The approved product's Medication Guide or prescribing information is linked when available.

10. Contact

For side effects or prescription instructions, contact the treating provider or dispensing pharmacist right away. Emergencies: 911. Administrative questions: pyper@altirastelemeds.com. Report side effects to the FDA through MedWatch.

All legal and compliance pages

How It WorksGet Started